Guangzhou Kingmed Diagnostics Group Co Ltd

On September 24, major A-share indices opened lower, while the media sector bucked the trend in early trading. Xinhua Winshare hit its fifth consecutive limit-up, Xinhua Media its fourth, and Topway Video its third, with Guangdong Media and Inner Mongolia Xinhua Distribution also among the top gainers. In news, Xinhua Winshare recently announced plans to use its own funds to acquire the 100% equity stake in Sichuan Nationalities Publishing House held by its controlling shareholder, Sichuan Xinhua Publishing and Distribution Group, for 346 million yuan. The transaction constitutes a related-party transaction but does not constitute a major asset restructuring. On the same day, Bairui Gene debuted on the Beijing Stock Exchange, opening 347.23% higher and rising more than 400% as of press time, with an issue price of 16.77 yuan. The company focuses on the research, production, and sales of biomedical materials and other products. The AI-driven drug discovery concept saw a sudden surge, with Berry Genomics hitting the daily limit-up in a straight line, and BGI Genomics, Rongtai Health, Saili Medical, Sino Biological, and Kingmed Diagnostics following higher. This came after the Ministry of Industry and Information Technology and nine other departments jointly issued the 15th Five-Year Plan for the development of the pharmaceutical industry, which explicitly calls for accelerating the use of artificial intelligence and other new technologies to empower drug research and development. The coal sector fluctuated higher, with Yunnan Coal Energy hitting the daily limit-up, briefly opening, and then sealing the limit-up again. Zhengzhou Coal Mining Machinery, Liaoning Energy, Antai Group, and Shaanxi Heimao followed higher. On September 24, the benchmark price for thermal coal on SunSirs was 989.50 yuan per ton, up 13.02% from 875.50 yuan per ton at the beginning of the month. The robotics concept saw localized movement, with Xiangyang Automobile Bearing hitting the limit-up, and Ningbo Dongli, Wanxiang Qianchao, Nanfang Precision, Sanhua Intelligent Controls, and Tuopu Group following higher. Tesla CEO Elon Musk said in an interview on September 23 that he predicts there will be at least 1 billion humanoid robots within 10 years or less, perhaps 10 billion in the next 15 years, and possibly 100 billion in the next 20 years. The real estate sector fell sharply, with Huali Family hitting the limit-down, Huayuan Holdings touching the limit-down, and Greenland Holdings, Heungkong Holdings, China Vanke, and Risesun Development quickly following lower.

KingMed Diagnostics released its 2026 interim report, showing a net profit attributable to shareholders of 190 million yuan for the first half, swinging from a loss in the same period last year. Revenue was 2.88 billion yuan, down 3.8 percent year on year. Net profit attributable to shareholders excluding non-recurring items was 203 million yuan, compared with a loss of 97.96 million yuan a year earlier. Net operating cash flow was 243 million yuan, down 30.8 percent year on year. Second-quarter revenue was 1.53 billion yuan, up 0.2 percent year on year, with net profit attributable to shareholders of 147 million yuan. The company said that against the backdrop of healthcare reform, an ageing population and the development of county-level medical systems, the third-party medical testing industry is adjusting its pricing methods, service scenarios and capability structure. KingMed has set a medium- and long-term strategic goal of building a globally leading smart service platform for medical diagnostics.

KingMed Diagnostics announced that as of July 31, 2026, the company had repurchased 6.77 million shares, accounting for 1.46% of total share capital, with a total repurchase amount of 178 million yuan, at a price range of 23.36 yuan to 28.79 yuan per share. In the first quarter of 2026, the company achieved revenue of 1.351 billion yuan and net profit attributable to the parent company of 42.79 million yuan.